Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Short Interest Update

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) saw a large growth in short interest during the month of November. As of November 30th, there was short interest totalling 33,500 shares, a growth of 225.2% from the November 15th total of 10,300 shares. Based on an average trading volume of 4,900 shares, the days-to-cover ratio is currently 6.8 days.

Fidelity Disruptive Medicine ETF Stock Down 0.3 %

Shares of Fidelity Disruptive Medicine ETF stock traded down $0.08 during trading on Friday, hitting $25.57. The stock had a trading volume of 3,424 shares, compared to its average volume of 5,423. The company has a market capitalization of $53.70 million, a PE ratio of 35.73 and a beta of 0.94. The stock has a 50 day simple moving average of $25.91 and a 200 day simple moving average of $25.24. Fidelity Disruptive Medicine ETF has a 1 year low of $22.82 and a 1 year high of $26.68.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Fidelity Disruptive Medicine ETF stock. Wealth Enhancement Advisory Services LLC boosted its stake in shares of Fidelity Disruptive Medicine ETF (NASDAQ:FMED) by 3.7% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 539,827 shares of the company’s stock after purchasing an additional 19,240 shares during the quarter. Wealth Enhancement Advisory Services LLC owned about 25.46% of Fidelity Disruptive Medicine ETF worth $14,192,000 at the end of the most recent quarter.

Fidelity Disruptive Medicine ETF Company Profile

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.